(Reuters) - California-based Mapp Biopharmaceutical Inc is making progress in efforts to boost production of the experimental Ebola treatment ZMapp, as the deadly virus continues to spread through West Africa and beyond, the company said Friday.
via Reuters: Health News Read More Here..
No comments:
Post a Comment